Production (Stage)
Jolt Health Inc.
JTHTF
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 270.00K | 48.40K | 149.00K | 158.00K | -46.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 270.00K | 48.40K | 149.00K | 158.00K | -46.00K |
| Operating Income | -270.00K | -48.40K | -149.00K | -158.00K | 46.00K |
| Income Before Tax | -485.80K | -50.80K | -152.00K | -157.40K | -218.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -485.80K | -50.80K | -152.00K | -157.40K | -218.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -485.80K | -50.80K | -152.00K | -157.40K | -218.90K |
| EBIT | -270.00K | -48.40K | -149.00K | -158.00K | 46.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.08 | -0.01 | -0.02 | -0.04 | -0.06 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.01 | -0.02 | 0.01 |
| EPS Diluted | -0.08 | -0.01 | -0.02 | -0.04 | -0.06 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.01 | -0.02 | 0.01 |
| Average Basic Shares Outstanding | 6.37M | 6.36M | 6.36M | 3.97M | 3.87M |
| Average Diluted Shares Outstanding | 6.37M | 6.36M | 6.36M | 3.97M | 3.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |